Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (66)	12/3/1997 12:37:00 PM
From: Grainne	Read Replies (1) \| Respond to of 666

Could you explain briefly the differences between Bexxar and Rituxan? I was really excited by the headlines when Rituxan was approved, but in the fine print it seems that it is used only after chemotherapy and a lot of other treatments, and it is a treatment which may prolong life or cause remission to occur, not a cure. Is my understanding correct? Does Bexxar do more? One of my coworkers jumped ship to do marketing for Coulter a couple of months ago, and he was ecstatic about its prospects. What do you think, comparatively speaking?